                         SEQUENCE LISTING

<110>  Universittsmedizin der Johannes Gutenberg-Universitt 
       Mainz
 
<120>  Inhibitors of the Tissue Factor-Protease Activated Receptor 2 
       (TF-PAR2) signaling pathway for use in the treatment or 
       prevention of heart failure (HF) and associated or resulting 
       diseases

<130>  TF-Signalling

<150>  EP20208835
<151>  2020-11-20

<150>  EP21194468
<151>  2021-09-02

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  84
<212>  PRT
<213>  Ancylostoma caninum

<400>  1

Lys Ala Thr Met Gln Cys Gly Glu Asn Glu Lys Tyr Asp Ser Cys Gly 
1               5                   10                  15      


Ser Lys Glu Cys Asp Lys Lys Cys Lys Tyr Asp Gly Val Glu Glu Glu 
            20                  25                  30          


Asp Asp Glu Glu Pro Asn Val Pro Cys Leu Val Arg Val Cys His Gln 
        35                  40                  45              


Asp Cys Val Cys Glu Glu Gly Phe Tyr Arg Asn Lys Asp Asp Lys Cys 
    50                  55                  60                  


Val Ser Ala Glu Asp Cys Glu Leu Asp Asn Met Asp Phe Ile Tyr Pro 
65                  70                  75                  80  


Gly Thr Arg Asn 
                


<210>  2
<211>  85
<212>  PRT
<213>  Ancylostoma caninum

<400>  2

Lys Ala Thr Met Gln Cys Gly Glu Asn Glu Lys Tyr Asp Ser Cys Gly 
1               5                   10                  15      


Ser Lys Glu Cys Asp Lys Lys Cys Lys Tyr Asp Gly Val Glu Glu Glu 
            20                  25                  30          


Asp Asp Glu Glu Pro Asn Val Pro Cys Leu Val Arg Val Cys His Gln 
        35                  40                  45              


Asp Cys Val Cys Glu Glu Gly Phe Tyr Arg Asn Lys Asp Asp Lys Cys 
    50                  55                  60                  


Val Ser Ala Glu Asp Cys Glu Leu Asp Asn Met Asp Phe Ile Tyr Pro 
65                  70                  75                  80  


Gly Thr Arg Asn Pro 
                85  


